{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:33:12Z","timestamp":1773297192829,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["ASPIRE Award in Rheumatology Research"],"award-info":[{"award-number":["ASPIRE Award in Rheumatology Research"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR062207"],"award-info":[{"award-number":["R01 AR062207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10067-016-3467-7","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T13:05:27Z","timestamp":1478696727000},"page":"507-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study"],"prefix":"10.1007","volume":"36","author":[{"given":"Jennifer","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Yeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosy","family":"Rajbhandary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Fadle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Thurner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Stohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"issue":"22","key":"3467_CR1","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","volume":"343","author":"JM Bathon","year":"2000","unstructured":"Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343(22):1586\u20131593","journal-title":"N Engl J Med"},{"issue":"5","key":"3467_CR2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"EC Keystone","year":"2004","unstructured":"Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50(5):1400\u20131411","journal-title":"Arthritis Rheum"},{"issue":"22","key":"3467_CR3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde D, St Clair EW, Furst DE, Breedveld FC, Kalden JR et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343(22):1594\u20131602","journal-title":"N Engl J Med"},{"issue":"9194","key":"3467_CR4","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 354(9194):1932\u20131939","journal-title":"Lancet"},{"issue":"4","key":"3467_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253\u2013259","journal-title":"N Engl J Med"},{"issue":"1","key":"3467_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA et al (2003) Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35\u201345","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3467_CR7","first-page":"2158","volume":"34","author":"A Pachot","year":"2007","unstructured":"Pachot A, Arnaud B, Marrote H, Cazalis M-A, Diasparra J, Gouraud A et al (2007) Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response. J Rheumatol 34(11):2158\u20132161","journal-title":"J Rheumatol"},{"issue":"1","key":"3467_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pharmthera.2011.10.003","volume":"133","author":"L C-j","year":"2012","unstructured":"C-j L, Progranulin BX (2012) A growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 133(1):124\u2013132","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3467_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T et al (2010) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207(1):117\u2013128","journal-title":"J Exp Med"},{"issue":"6028","key":"3467_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang W, Lu Y, Tian Q-Y, Zhang Y, Guo F-J, Liu G-Y et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332(6028):478\u2013484","journal-title":"Science"},{"issue":"27","key":"3467_CR11","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1016\/j.biomaterials.2013.05.030","volume":"34","author":"YP Zhao","year":"2013","unstructured":"Zhao YP, Tian QY, Frenkel S, Liu CJ (2013) The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF\/TNFR signaling. Biomaterials 34(27):6412\u20136421","journal-title":"Biomaterials"},{"issue":"12","key":"3467_CR12","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1136\/annrheumdis-2014-205779","volume":"74","author":"YP Zhao","year":"2015","unstructured":"Zhao YP, Liu B, Tian QY, Wei JL, Richbourgh B, Liu CJ (2015) Progranulin protects against osteoarthritis through interacting with TNF-\u03b1 and \u03b2-catenin signalling. Ann Rheum Dis 74(12):2244\u20132253","journal-title":"Ann Rheum Dis"},{"key":"3467_CR13","doi-asserted-by":"crossref","unstructured":"Cerezo LA, Kuklova M, Hulejova H, Vernerova Z, Kasprikova N, Veigl D, et al. Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators of Inflammation. 2015.","DOI":"10.1155\/2015\/740357"},{"issue":"5","key":"3467_CR14","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1007\/s10753-014-9911-4","volume":"37","author":"Y Yamamoto","year":"2014","unstructured":"Yamamoto Y, Takemura M, Serrero G, Hayashi J, Yue B, Tsuboi A et al (2014) Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis. Inflammation 37(5):1806\u20131813","journal-title":"Inflammation"},{"issue":"9","key":"3467_CR15","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3467_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2012.10.003","volume":"42","author":"L Thurner","year":"2013","unstructured":"Thurner L, Preuss KD, Fadle N, Regitz E, Klemm P, Zaks M et al (2013) Progranulin antibodies in autoimmune diseases. J Autoimmun 42:29\u201338","journal-title":"J Autoimmun"},{"issue":"5","key":"3467_CR17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1523\/JNEUROSCI.5757-10.2011","volume":"31","author":"A Capell","year":"2011","unstructured":"Capell A, Liebscher S, Fellerer K, Brouwers N, Willem M, Lammich S et al (2011) Rescue of Progranulin Deficiency Associated with Frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J Neurosci 31(5):1885\u20131894","journal-title":"J Neurosci"},{"issue":"6","key":"3467_CR18","doi-asserted-by":"publisher","first-page":"R244","DOI":"10.1186\/ar4087","volume":"14","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M et al (2012) Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Research & Therapy 14(6):R244","journal-title":"Arthritis Research & Therapy"},{"key":"3467_CR19","doi-asserted-by":"crossref","unstructured":"Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M et al (2015) Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. Arthritis Research & Therapy 17","DOI":"10.1186\/s13075-015-0547-z"},{"issue":"6","key":"3467_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","volume":"111","author":"J Zhu","year":"2002","unstructured":"Zhu J, Nathan C, Jin WW, Sim D, Ashcroft GS, Wahl SM et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111(6):867\u2013878","journal-title":"Cell"},{"issue":"10","key":"3467_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00109-003-0474-3","volume":"81","author":"ZH He","year":"2003","unstructured":"He ZH, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. Journal of Molecular Medicine-Jmm 81(10):600\u2013612","journal-title":"Journal of Molecular Medicine-Jmm"},{"issue":"7","key":"3467_CR22","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock K, Fr\u00f6hlich L, Sixt M, L\u00e4mmermann T, Pfister H, Bateman A et al (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Investig 118(7):2438\u20132447","journal-title":"J Clin Investig"},{"issue":"6","key":"3467_CR23","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1186\/ar4406","volume":"15","author":"L Thurner","year":"2013","unstructured":"Thurner L, Zaks M, Preuss K-D, Fadle N, Regitz E, Ong MF et al (2013) Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Research & Therapy 15(6):R211","journal-title":"Arthritis Research & Therapy"},{"key":"3467_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2015.05.002","volume":"61","author":"L Thurner","year":"2015","unstructured":"Thurner L, Fadle N, Regitz E, Kemele M, Klemm P, Zaks M et al (2015) The molecular basis for development of proinflammatory autoantibodies to progranulin. J Autoimmun 61:17\u201328","journal-title":"J Autoimmun"},{"key":"3467_CR25","doi-asserted-by":"crossref","unstructured":"Wei F, Zhang Y, Jian J, Mundra JJ, Tian Q, Lin J et al (2014) PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. Scientific Reports 4","DOI":"10.1038\/srep07023"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3467-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:48:10Z","timestamp":1589442490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3467-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]},"assertion":[{"value":"30 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The protocol was reviewed and approved by the LAC\u00a0+\u00a0USC Institutional Review Board (Protocol HS-12-00394). Written informed consent was obtained from all subjects prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}